PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1799474
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1799474
Global Interventional Cardiology Devices Market Size Study & Forecast, by Product, by End User and Regional Forecasts 2025-2035
The Global Interventional Cardiology Devices Market is valued at approximately USD 16.69 billion in 2024 and is poised to expand at an exceptional CAGR of 33.97% from 2025 to 2035. Interventional cardiology devices, encompassing an array of innovative technologies, play a pivotal role in diagnosing and treating cardiovascular diseases through minimally invasive procedures. These devices, ranging from coronary stents and angioplasty balloons to structural heart devices and embolic protection systems, are engineered to restore optimal blood flow, repair structural anomalies, and reduce procedural risks. The market is being propelled forward by the relentless rise in cardiovascular disease prevalence, the global surge in aging populations, and the escalating preference for advanced, less-invasive treatment modalities. Furthermore, continuous technological innovation, such as bioresorbable scaffolds and next-generation drug-eluting stents, has unlocked unprecedented opportunities for improved patient outcomes and reduced recovery times.
The mounting global burden of heart disease has intensified the demand for high-precision interventional tools capable of addressing complex cardiovascular conditions. According to the World Health Organization, cardiovascular diseases remain the leading cause of mortality worldwide, claiming approximately 17.9 million lives annually. The growing need for effective interventions has driven healthcare providers to adopt cutting-edge catheter-based techniques, which offer reduced hospitalization periods and improved procedural success rates. Rising healthcare investments, expanding insurance coverage for cardiac procedures, and an uptick in large-scale public health initiatives to combat heart disease have further fueled market growth. However, challenges such as the high cost of advanced devices, stringent regulatory pathways, and the shortage of highly skilled interventional cardiologists may temper the pace of expansion in certain regions.
From a geographical standpoint, North America commands the lion's share of the global market, underpinned by its sophisticated healthcare infrastructure, high per capita healthcare expenditure, and robust adoption of next-generation interventional devices. The United States, in particular, benefits from well-established clinical guidelines and a strong reimbursement ecosystem, ensuring widespread access to advanced cardiovascular care. Europe follows closely, driven by continuous innovation, supportive regulatory frameworks, and proactive initiatives for early diagnosis and treatment of heart disease. Meanwhile, the Asia Pacific region is anticipated to witness the most rapid growth over the forecast period, spurred by demographic shifts, increasing awareness of cardiovascular health, and significant investments in hospital expansions across emerging economies such as China and India. Additionally, growing collaborations between local manufacturers and global medtech leaders are enabling cost-effective device production, making life-saving interventions more accessible across the region.
Major market players included in this report are:
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic plc
- Terumo Corporation
- Edwards Lifesciences Corporation
- Johnson & Johnson (Biosense Webster)
- Cardinal Health, Inc.
- B. Braun Melsungen AG
- Cook Medical LLC
- Philips Healthcare
- Siemens Healthineers AG
- Merit Medical Systems, Inc.
- Nipro Corporation
- Asahi Intecc Co., Ltd.
- Shockwave Medical, Inc.
Global Interventional Cardiology Devices Market Report Scope:
- Historical Data - 2023, 2024
- Base Year for Estimation - 2024
- Forecast period - 2025-2035
- Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:
By Product:
- Coronary Stents
- Bare-metal Stent (BMS)
- Drug-eluting Stent (DES)
- Others
- Structural Heart Devices
- Heart Valves
- Occluders & Others
- Angioplasty Balloons
- Catheters
- Diagnostic Catheters (Angiography, IVUS, Others)
- Treatment Catheters (Atherectomy, Thrombectomy, Ablation, Others)
- Embolic Protection Devices
- Others
By End User:
- Hospitals & ASCs
- Catheterization Labs & Others
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Key Takeaways:
- Market Estimates & Forecast for 10 years from 2025 to 2035.
- Annualized revenues and regional level analysis for each market segment.
- Detailed analysis of geographical landscape with Country level analysis of major regions.
- Competitive landscape with information on major players in the market.
- Analysis of key business strategies and recommendations on future market approach.
- Analysis of competitive structure of the market.
- Demand side and supply side analysis of the market.
Table of Contents
Chapter 1. Global Interventional Cardiology Devices Market Report Scope & Methodology
- 1.1. Research Objective
- 1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
- 1.3. Research Attributes
- 1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
- 1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study
Chapter 2. Executive Summary
- 2.1. CEO/CXO Standpoint
- 2.2. Strategic Insights
- 2.3. ESG Analysis
- 2.4. key Findings
Chapter 3. Global Interventional Cardiology Devices Market Forces Analysis
- 3.1. Market Forces Shaping The Global Interventional Cardiology Devices Market (2024-2035)
- 3.2. Drivers
- 3.2.1. Growing cardiovascular disease burden and aging demographics
- 3.2.2. Rapid uptake of minimally invasive interventions and next-generation stent/structural heart technologies
- 3.3. Restraints
- 3.3.1. High procedural/device costs and stringent regulatory requirements
- 3.3.2. Shortage of skilled interventional cardiologists and uneven reimbursement in emerging markets
- 3.4. Opportunities
- 3.4.1. Expansion of structural heart therapies (TAVR, TMVR, LAA closure) and imaging-guided PCI
- 3.4.2. Acceleration in APAC and outpatient/ASC settings with localized manufacturing and value-based models
Chapter 4. Global Interventional Cardiology Devices Industry Analysis
- 4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Porter's 5 Force Forecast Model (2024-2035)
- 4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
- 4.4. Top Investment Opportunities
- 4.5. Top Winning Strategies (2025)
- 4.6. Market Share Analysis (2024-2025)
- 4.7. Global Pricing Analysis And Trends 2025
- 4.8. Analyst Recommendation & Conclusion
Chapter 5. Global Interventional Cardiology Devices Market Size & Forecasts by Product 2025-2035
- 5.1. Market Overview
- 5.2. Global Growth Hormone Deficiency Market Performance - Potential Analysis (2025)
- 5.3. Coronary Stents
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
- 5.4. Structural Heart Devices
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035
- 5.5. Angioplasty Balloons
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market size analysis, by region, 2025-2035
- 5.6. Catheters
- 5.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.6.2. Market size analysis, by region, 2025-2035
- 5.7. Embolic Protection Devices
- 5.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.7.2. Market size analysis, by region, 2025-2035
- 5.8. Others
- 5.8.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.8.2. Market size analysis, by region, 2025-2035
Chapter 6. Global Interventional Cardiology Devices Market Size & Forecasts by End User 2025-2035
- 6.1. Market Overview
- 6.2. Global Growth Hormone Deficiency Market Performance - Potential Analysis (2025)
- 6.3. Hospitals & ASCs
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
- 6.4. Catheterization Labs & Others
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035
Chapter 7. Global Interventional Cardiology Devices Market Size & Forecasts by Region 2025-2035
- 7.1. Growth Hormone Deficiency Market, Regional Market Snapshot
- 7.2. Top Leading & Emerging Countries
- 7.3. North America Interventional Cardiology Devices Market
- 7.3.1. U.S. Interventional Cardiology Devices Market
- 7.3.1.1. Product breakdown size & forecasts, 2025-2035
- 7.3.1.2. End User breakdown size & forecasts, 2025-2035
- 7.3.2. Canada Interventional Cardiology Devices Market
- 7.3.2.1. Product breakdown size & forecasts, 2025-2035
- 7.3.2.2. End User breakdown size & forecasts, 2025-2035
- 7.3.1. U.S. Interventional Cardiology Devices Market
- 7.4. Europe Interventional Cardiology Devices Market
- 7.4.1. UK Interventional Cardiology Devices Market
- 7.4.1.1. Product breakdown size & forecasts, 2025-2035
- 7.4.1.2. End User breakdown size & forecasts, 2025-2035
- 7.4.2. Germany Interventional Cardiology Devices Market
- 7.4.2.1. Product breakdown size & forecasts, 2025-2035
- 7.4.2.2. End User breakdown size & forecasts, 2025-2035
- 7.4.3. France Interventional Cardiology Devices Market
- 7.4.3.1. Product breakdown size & forecasts, 2025-2035
- 7.4.3.2. End User breakdown size & forecasts, 2025-2035
- 7.4.4. Spain Interventional Cardiology Devices Market
- 7.4.4.1. Product breakdown size & forecasts, 2025-2035
- 7.4.4.2. End User breakdown size & forecasts, 2025-2035
- 7.4.5. Italy Interventional Cardiology Devices Market
- 7.4.5.1. Product breakdown size & forecasts, 2025-2035
- 7.4.5.2. End User breakdown size & forecasts, 2025-2035
- 7.4.6. Rest of Europe Interventional Cardiology Devices Market
- 7.4.6.1. Product breakdown size & forecasts, 2025-2035
- 7.4.6.2. End User breakdown size & forecasts, 2025-2035
- 7.4.1. UK Interventional Cardiology Devices Market
- 7.5. Asia Pacific Interventional Cardiology Devices Market
- 7.5.1. China Interventional Cardiology Devices Market
- 7.5.1.1. Product breakdown size & forecasts, 2025-2035
- 7.5.1.2. End User breakdown size & forecasts, 2025-2035
- 7.5.2. India Interventional Cardiology Devices Market
- 7.5.2.1. Product breakdown size & forecasts, 2025-2035
- 7.5.2.2. End User breakdown size & forecasts, 2025-2035
- 7.5.3. Japan Interventional Cardiology Devices Market
- 7.5.3.1. Product breakdown size & forecasts, 2025-2035
- 7.5.3.2. End User breakdown size & forecasts, 2025-2035
- 7.5.4. Australia Interventional Cardiology Devices Market
- 7.5.4.1. Product breakdown size & forecasts, 2025-2035
- 7.5.4.2. End User breakdown size & forecasts, 2025-2035
- 7.5.5. South Korea Interventional Cardiology Devices Market
- 7.5.5.1. Product breakdown size & forecasts, 2025-2035
- 7.5.5.2. End User breakdown size & forecasts, 2025-2035
- 7.5.6. Rest of APAC Interventional Cardiology Devices Market
- 7.5.6.1. Product breakdown size & forecasts, 2025-2035
- 7.5.6.2. End User breakdown size & forecasts, 2025-2035
- 7.5.1. China Interventional Cardiology Devices Market
- 7.6. Latin America Interventional Cardiology Devices Market
- 7.6.1. Brazil Interventional Cardiology Devices Market
- 7.6.1.1. Product breakdown size & forecasts, 2025-2035
- 7.6.1.2. End User breakdown size & forecasts, 2025-2035
- 7.6.2. Mexico Interventional Cardiology Devices Market
- 7.6.2.1. Product breakdown size & forecasts, 2025-2035
- 7.6.2.2. End User breakdown size & forecasts, 2025-2035
- 7.6.1. Brazil Interventional Cardiology Devices Market
- 7.7. Middle East and Africa Interventional Cardiology Devices Market
- 7.7.1. UAE Interventional Cardiology Devices Market
- 7.7.1.1. Product breakdown size & forecasts, 2025-2035
- 7.7.1.2. End User breakdown size & forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) Interventional Cardiology Devices Market
- 7.7.2.1. Product breakdown size & forecasts, 2025-2035
- 7.7.2.2. End User breakdown size & forecasts, 2025-2035
- 7.7.3. South Africa Interventional Cardiology Devices Market
- 7.7.3.1. Product breakdown size & forecasts, 2025-2035
- 7.7.3.2. End User breakdown size & forecasts, 2025-2035
- 7.7.1. UAE Interventional Cardiology Devices Market
Chapter 8. Competitive Intelligence
- 8.1. Top Market Strategies
- 8.2. Abbott Laboratories
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
- 8.3. Boston Scientific Corporation
- 8.4. Medtronic plc
- 8.5. Terumo Corporation
- 8.6. Edwards Lifesciences Corporation
- 8.7. Johnson & Johnson (Biosense Webster)
- 8.8. Cardinal Health, Inc.
- 8.9. B. Braun Melsungen AG
- 8.10. Cook Medical LLC
- 8.11. Philips Healthcare
- 8.12. Siemens Healthineers AG
- 8.13. Merit Medical Systems, Inc.
- 8.14. Nipro Corporation
- 8.15. Asahi Intecc Co., Ltd.
- 8.16. Shockwave Medical, Inc.
